All In Biotech

Drug Trial Radar · NCT06058585

The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect

Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 2,000 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

2,000

Planned (sponsor's estimate)

Start

Sep 4, 2024

Primary completion

Dec 31, 2029

Study completion Dec 31, 2029

Sponsor

Lead sponsor
The George InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 28, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Factorial
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

CAPTIVATE is an international, multi-centre, Phase III, adaptive, platform, randomised controlled trial in people with chronic kidney disease (CKD). CAPTIVATE aims to find the best treatment, or combination of treatments, that slow the progression of CKD so that fewer people develop kidney failure. CAPTIVATE provides a research platform that allows many treatment-related questions to be answered within a common trial set-up. CAPTIVATE includes multiple domains examining different therapies for CKD. Participants may enrol in one or more domains and domains will be added and closed over time. The platform operates under a core protocol with each domain described in a domain specific appendix.

Conditions

  • Chronic Kidney Diseases

Interventions

  • FinerenoneDrug

    Finerenone 10mg or 20mg tablets, oral, once daily

  • Placebo FinerenoneDrug

    Finerenone matched placebo tablets, oral, once daily

  • SemaglutideDrug

    Semaglutide 1.0mg or 2.4mg pen injector, subcutaneous injection, once weekly

  • Placebo semaglutideDrug

    Semaglutide matched pen injector, subcutaneous injection, once weekly

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Core Primary Outcome MeasureTime frame: From randomisation to week 108
  2. MRA Domain Primary Outcome MeasureTime frame: From week 4 to week 108
  3. GLP1-RA Domain Primary Outcome MeasureTime frame: From week 0 to week 108

Locations

51 sites in 5 countries. Site status is shown where the registry gives one.

  • The Canberra Hospital

    Garran, Australian Capital Territory, Australia · Recruiting

  • Nepean Blue Mountains Local Health District

    Kingswood, New South Wales, Australia · Recruiting

  • St George Hospital

    Kogarah, New South Wales, Australia · Recruiting

  • John Hunter Hospital

    New Lambton Heights, New South Wales, Australia · Recruiting

  • Westmead Hospital

    Westmead, New South Wales, Australia · Recruiting

  • Sunshine Coast Hospital and Health Service

    Birtinya, Queensland, Australia · Recruiting

  • Townsville University Hospital

    Douglas, Queensland, Australia · Recruiting

  • West Moreton Hospital & Health Service

    Ipswich, Queensland, Australia · Recruiting

  • Gold Coast Hospital and Health Service

    Southport, Queensland, Australia · Recruiting

  • Royal Adelaide

    Adelaide, South Australia, Australia · Recruiting

  • Lyell McEwin Hospital

    Elizabeth Vale, South Australia, Australia · Recruiting

  • Austin Health

    Heidelberg, Victoria, Australia · Recruiting

  • South Metropolitan Health Service, Fiona Stanley Hospital

    Murdoch, Western Australia, Australia · Recruiting

  • Max Superspeciality Hospital, Dehradun

    Dehradun, India · Not yet recruiting

  • Max Superspecialty Hospital, Ghaziabad

    Ghaziabad, India · Recruiting

  • Aarupadai Veedu Medical College & Hospital (AVMCH), Puducherry

    Puducherry, India · Recruiting

  • Gitam Institute of Medical Sciences and Research

    Visakhapatnam, Andhra Pradesh, India · Recruiting

  • Patna Medical College and Hospital

    Patna, Bihar, India · Recruiting

  • DKS Super Speciality Hospital, Raipur

    Raipur, Chhattisgarh, India · Recruiting

  • Mysore Medical College

    Dehradun, Dehradun, India · Recruiting

  • GCS Medical College, Hospital & Research Centre

    Ahmedabad, Gujarat, India · Recruiting

  • Aman Hospital & Research Center Vadodara

    Vadodara, Gujarat, India · Recruiting

  • Father Muller Medical College Hospital

    Mangaluru, Karnataka, India · Recruiting

  • Dr Moopen's Medical College

    Meppādi, Kerala, India · Recruiting

  • CARE-CHL Hospital

    Indore, Madhya Pradesh, India · Recruiting

  • Medway Hospital

    Chennai, Tamil Nadu, India · Recruiting

  • Yashoda Hospital Hitec City

    Hyderabad, Telangana, India · Recruiting

  • Apollo Hospitals

    Hyderabad, Telangana, India · Recruiting

  • Charak Hospital and Research Centre

    Lucknow, Uttar Pradesh, India · Recruiting

  • Shri Guru Ram Rai Medical College and Shri Mahant Indiresh Hospital

    Dehradun, Uttarakhand, India · Recruiting

  • Fortis Hospital

    Kolkata, West Bengal, India · Recruiting

  • North Bengal Medical College & Hospital

    Siliguri, West Bengal, India · Recruiting

  • Health New Zealand, Te Whatu Ora Waitemata, North Shore Hospital

    Auckland, New Zealand · Recruiting

  • Auckland City Hospital

    Auckland, New Zealand · Recruiting

  • Aotearoa Clinical Trials Trust, Middlemore Hospital

    Auckland, New Zealand · Recruiting

  • 201 Great King Street, Central Dunedin, Dunedin 9016, New Zealand

    Dunedin, New Zealand · Recruiting

  • Midcentral - Palmerston North Hospital

    Palmerston North, New Zealand · Recruiting

  • Private Bag 9742 Maunu Road, Horahora, Whangārei 0148, New Zealand

    Whangarei, New Zealand · Recruiting

  • Health New Zealand, Te Whatu Ora Te Matau a Maui, Hawke's Bay Hospital

    Hastings, Hawkes Bay, New Zealand · Recruiting

  • Hospital Germans Trias i Pujol

    Badalona, Barcelona, Spain · Active not recruiting

Showing 40 of 51 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.